Skip to NavigationSkip to content

Pharmafile - Research and Development News

A new report from Public Health England (PHE) has illuminated the primary health concerns in UK society today, revealing the extent of rising...
The American pharmaceutical industry trade lobby PhRMA has suggested that hospitals are to blame for high drug prices as the furore around drug...
The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug producing company,...
Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are 16 weeks’ worth of...
To find out more, check out this week’s Top 10 most popular articles on Pharmafile.com now!
Gilead and Galapagos have announced that their jointly-developed selective JAK1 inhibitor filgotinib has met its primary endpoint in a Phase 2...
Israeli multinational Teva Pharmaceutical has decided to discontinue the development of laquinimod. As such, all rights for the orally administered...
Ketamine’s antidepressant effect works through the activation of the brains opioid receptors, a new study published in The American Journal of...
The FDA is to incorporate real-world data elements to a greater degree into its regulatory decision-making framework in a bid to “answer questions...
Puma Biotechnology have received European Commission marketing authorisation for Nerlynx (neratinib) despite prior concerns as to the safety and...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches